C9orf72 intermediate expansions of 24–30 repeats are associated with ALS

被引:0
作者
Alfredo Iacoangeli
Ahmad Al Khleifat
Ashley R. Jones
William Sproviero
Aleksey Shatunov
Sarah Opie-Martin
Karen E. Morrison
Pamela J. Shaw
Christopher E. Shaw
Isabella Fogh
Richard J. Dobson
Stephen J. Newhouse
Ammar Al-Chalabi
机构
[1] King’s College London,Department of Biostatistics and Health Informatics
[2] King’s College London,Department of Basic and Clinical Neuroscience
[3] Maurice Wohl Clinical Neuroscience Institute,The Alzheimer’s Disease Neuroimaging Initiative, Center for Imaging of Neurodegenerative Disease, San Francisco VA Medical Center
[4] University of California,Faculty of Medicine
[5] University of Southampton,Sheffield Institute for Translational Neuroscience
[6] University Hospital Southampton,UK Dementia Research Institute
[7] University of Sheffield,Department of Neurology and Laboratory of Neuroscience
[8] King’s College London,Farr Institute of Health Informatics Research
[9] IRCCS Istituto Auxologico Italiano,undefined
[10] UCL Institute of Health Informatics,undefined
[11] University College London,undefined
[12] National Institute for Health Research (NIHR) Biomedical Research Centre and Dementia Unit at South London and Maudsley NHS Foundation Trust and King’s College London,undefined
[13] King’s College Hospital,undefined
来源
Acta Neuropathologica Communications | / 7卷
关键词
Repeat expansion; ALS; Genetics; Whole-genome sequencing; Next-generation sequencing;
D O I
暂无
中图分类号
学科分类号
摘要
The expansion of a hexanucleotide repeat GGGGCC in C9orf72 is the most common known cause of ALS accounting for ~ 40% familial cases and ~ 7% sporadic cases in the European population. In most people, the repeat length is 2, but in people with ALS, hundreds to thousands of repeats may be observed. A small proportion of people have an intermediate expansion, of the order of 20 to 30 repeats in size, and it remains unknown whether intermediate expansions confer risk of ALS in the same way that massive expansions do. We investigated the association of this intermediate repeat with ALS by performing a meta-analysis of four previously published studies and a new British/Alzheimer’s Disease Neuroimaging Initiative dataset of 1295 cases and 613 controls. The final dataset comprised 5071 cases and 3747 controls. Our meta-analysis showed association between ALS and intermediate C9orf72 repeats of 24 to 30 repeats in size (random-effects model OR = 4.2, 95% CI = 1.23–14.35, p-value = 0.02). Furthermore, we showed a different frequency of the repeat between the northern and southern European populations (Fisher’s exact test p-value = 5 × 10− 3). Our findings provide evidence for the association between intermediate repeats and ALS (p-value = 2 × 10− 4) with direct relevance for research and clinical practice by showing that an expansion of 24 or more repeats should be considered pathogenic.
引用
收藏
相关论文
共 217 条
  • [1] Al-Chalabi A(2016)Amyotrophic lateral sclerosis: moving towards a new classification system The Lancet Neurology 15 1182-1194
  • [2] Hardiman O(2013)Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature Neuroepidemiology 41 118-130
  • [3] Kiernan MC(2006)Amyotrophic lateral sclerosis in an urban setting J Neurol 253 1642-1643
  • [4] Chiò A(2013)The changing scene of amyotrophic lateral sclerosis Nat Rev Neurosci 14 248-256
  • [5] Rix-Brooks B(2011)Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS Neuron 72 245-844
  • [6] van den Berg LH(2006)A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia Neurology 66 839-268
  • [7] Chiò A(2011)A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD Neuron 72 257-994
  • [8] Logroscino G(2010)Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study The Lancet Neurology 9 986-876
  • [9] Traynor B(2009)Genome-wide association study identifies 19p13. 3 (UNC13A) and 9p21. 2 as susceptibility loci for sporadic amyotrophic lateral sclerosis Nat Genet 41 1083-124
  • [10] Collins J(2006)Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13. 2–21.3 Brain 129 868-150